NVO pushes for AI transformation, Bloom Energy and Oracle deepen partnership, and more
The healthcare giant saw sales of medications, which include Darzalex and Tremfya, increase 11% in the first three months of the year
Johnson & Johnson reported first-quarter earnings that beat ​Wall Street expectations on Tuesday and raised its full-year forecast, as strong demand for cancer ‌drug Darzalex and psoriasis treatme
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a 3.1% increase in the quarterly dividend, from $1.30 per share to $1.34 pe
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) today announced results for first-quarter 2026. “Johnson & Johnson had a strong start to 2026 and is delivering on its promise for
The drug and medical-device giant has been working to ensure consistent growth after losing patent protection for its blockbuster Stelara.
Douglas Lane and Associates LLC grew its stake in Johnson and Johnson (NYSE: JNJ) by 1.9% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange
Apollon Wealth Management LLC raised its stake in Johnson and Johnson (NYSE: JNJ) by 2.7% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and E
The Dow Jones Industrial Average enters the week in the spotlight with four of the 30 component stocks set to report quarterly earnings results this week.
JNJ edges out LLY in a tight pharma showdown, backed by stronger valuation and stock performance despite Lilly's explosive GLP-1-driven growth.
It can be an interesting proposition to replace your salary with dividend stocks. However, it isn't as easy as it sounds. Replacing a salary of $85,000 in retirement through dividend stocks needs rese
Greenberg Financial Group bought a new stake in shares of Johnson and Johnson (NYSE: JNJ) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The in
Roffman Miller Associates Inc. PA lifted its stake in Johnson and Johnson (NYSE: JNJ) by 1.7% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. Th
OFI Invest Asset Management raised its position in shares of Johnson and Johnson (NYSE: JNJ) by 29.9% during the undefined quarter, according to its most recent disclosure with the Securities and Exch
Fiduciary Alliance LLC boosted its stake in shares of Johnson and Johnson (NYSE: JNJ) by 17.9% in the undefined quarter, according to the company in its most recent disclosure with the Securities and
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE